Drug screening of these models have revealed multiple genetic dependencies for preclinical development, which are currently being validated and explored in more depth in the lab. We have specific ...

Preclinical and early clinical trials can make the entire drug development process more effective and efficient. But only when the outcomes of those early trials accurately translate to later clinical ...

Off-target drug toxicities are a major roadblock to getting urgently needed drugs to market, contributing to the high attrition rates during both preclinical and clinical development. Now more ...

In this GEN webinar, experts from WuXi AppTec will share essential strategies and methodologies for accelerating pre-clinical ...

Dr. Carolina Gandara, Head of Retina Assay Development at Newcells Biotech, leads internal and external projects within the ...

Absci Corporation has secured key partnerships but lacks advanced assets. Find out why ABSI stock is still a speculative ...

The business combination of two AI-powered drug discovery and development companies, Recursion (Nasdaq: RXRX) and Exscientia ...

Altasciences, a trusted drug development research partner for over 30 years, continues its commitment to providing world-class bioanalytical services. This core business supports both preclinical and ...

Byondis B.V., an independent clinical stage biopharmaceutical company creating innovative targeted medicines for patients ...

The BiaB advantages over traditional methods of RNA manufacturing, include high throughput of high-quality pharmaceutical ...